Previous Article | Next Article ![]()
Infection and Immunity, January 2000, p. 125-132, Vol. 68, No. 1
Department of Microbiology, Pathology, and
Parasitology, College of Veterinary Medicine, North Carolina State
University, Raleigh, North Carolina 27606
Received 25 May 1999/Returned for modification 16 July
1999/Accepted 12 October 1999
In an effort to better understand genetic and cellular factors that
influence innate immunity, we examined host and bacterial factors
involved in the nonopsonic phagocytosis and killing of Escherichia coli K-12 by mouse macrophages. Unelicited
(resident) peritoneal macrophages from five different mouse strains,
BALB/c, C57BL/6, CD-1, C3H/HeJ, and C3H/HeN, were employed. Additional macrophage populations were obtained from CD-1 mice (bone
marrow-derived macrophages). Also, for BALB/c and C57BL/6 mice,
peritoneal macrophages elicited with either thioglycolate or proteose
peptone, bone marrow-derived macrophages, and macrophage-like cell
lines derived from the two strains were employed. Two E. coli K-12 strains that differed specifically in their abilities
to produce type 1 pili containing the adhesive protein FimH were
examined. The parameters used to assess macrophage bacteriocidal
activity were (i) the killing of internalized (gentamicin-protected)
E. coli during the approximately 4-h assay and (ii) the
initial rate at which internalized E. coli were eliminated.
Data on these parameters allowed the following conclusions: (i)
unelicited or proteose peptone-elicited peritoneal macrophages were
significantly better at eliminating internalized bacteria than
thioglycolate-elicited peritoneal macrophages, bone marrow-derived
macrophages, or macrophage cell lines; (ii) the host genetic background
had no significant effect upon the ability of unelicited peritoneal
macrophages to kill E. coli (even though the mouse strains
differ widely in their in vivo susceptibilities to bacterial
infection); and (iii) the FimH phenotype had no significant effect upon
E. coli survival once the bacterium was inside a
macrophage. Additionally, there was no correlation between the
bacteriocidal effectiveness of a macrophage population and the number
of bacteria bound per macrophage. However, macrophage populations that
were the least bacteriocidal tended to bind higher ratios of
FimH+ to FimH The mechanism by which bacteria are
taken up and killed by macrophages and other cells of the
reticuloendothelial system in the absence of normal or immune serum
components has been under study for a number of years (39).
This process has been referred to as nonopsonic phagocytosis.
Nonopsonic processes differ in a number of respects from the opsonic
mechanisms. One important difference is an increased rate of killing of
opsonized internalized bacteria (3, 54, 59). Nonopsonic
phagocytosis has been characterized as a primitive holdover from
protozoal ingestion mechanisms (40). However, since some
antibodies, particularly those directed against bacterial adhesins,
actually prevent phagocytosis (62), it may be fortunate that
this poorly understood mechanism is still in place.
One well-described bacterial ligand that mediates nonopsonic
phagocytosis is the type 1 pilus (8). These pili are
produced by many members of the Enterobacteriaceae
(12) and promote bacterial adherence to the mucosal surfaces
of a wide variety of hosts through a mannose-sensitive interaction with
receptors on eucaryotic cells (12). This adherence is
thought to allow the colonization of a number of host compartments
(42) and promote interindividual spread (4). Type
1 pili also mediate adherence to phagocytic cells (39). The
interactions between type 1 pili and neutrophils (58), mast
cells (30-32), macrophages (3), and other
leukocytes (45) have been some of the more carefully
examined interactions between bacteria and phagocytes.
Early and more recent work on the nature of the interaction of type 1 piliated Escherichia coli cells with macrophages indicates that one minor component of the pili, the product of the
fimH gene (FimH), is responsible for adherence
(25). Whereas this adherence, in effect, tethers the
piliated bacteria to macrophages and effectively increases the number
of bacteria bound compared to the number of fimH mutants
bound (25) and induces an oxidative burst (5, 15, 29,
41), reports on whether type 1 piliation actually results in an
increased rate of killing compared to that for nonpiliated or
FimH In order to better understand factors affecting innate host
susceptibility to bacterial diseases and also the role of type 1 pili
in the nonopsonic phagocytic process, we examined resident peritoneal
macrophages from five different mouse strains for their abilities to
kill E. coli that were phenotypically either
FimH+ or FimH Mouse strains and cell lines.
Male BALB/c, C3H/HeN, C3H/HeJ,
C57BL/6, and CD-1 mice 8 to 12 weeks of age were used in these
experiments. The mice were purchased from either Charles River
Laboratories (Wilmington, Mass.) or Taconic Farms (Germantown, N.Y.).
Mice were maintained under pathogen-free husbandry conditions and were
fed food and water ad libitum. Relevant genotypic and phenotypic
differences in the mouse strains and macrophage-like cell lines are
listed in Table 1.
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Host and Bacterial Factors Involved in the Innate
Ability of Mouse Macrophages To Eliminate Internalized Unopsonized
Escherichia coli
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
E. coli. The effect
of gamma interferon, fetal calf serum, and the recombination
proficiency of E. coli were examined as factors predicted
to influence intracellular bacterial killing. These had no effect upon
the rate of E. coli elimination by unelicited peritoneal macrophages.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
cells, under defined in vitro conditions, are
conflicting (5, 15, 16, 22, 25, 29). Reports agree that
leukocyte-bound type 1 piliated cells are better protected against
killing than opsonized FimH
E. coli cells
(3, 16, 55). This protection is due, at least in part, to a
difference in the compartmentalization of opsonized E. coli
versus that of FimH+ E. coli in bone
marrow-derived macrophages (3). Direct comparisons of
otherwise isogenic FimH+ and FimH
bacteria
(both unopsonized) suggest that there is a modest but statistically
significant increase in the survivability of FimH+ over
that of FimH
E. coli in microphages
(25).
. Also, for some mouse strains,
additional elicitation methods, anatomical sources, and derivation
methods were examined to see if these factors affected macrophage function.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Mouse and bacterial strains and cell lines used in
this study
Bacterial strains and growth conditions. Bacterial strains used in this study are shown in Table 1. All bacteria were grown in L broth (36) overnight with shaking to stationary phase. Prior to the bacteriocidal assay, bacteria were harvested by centrifugation (6,000 × g for 10 min), resuspended, and diluted to ca. 2 × 108 cells/ml in phosphate-buffered saline (PBS). Media used to assess bacterial numbers both before and after macrophage killing assays consisted of maltose tetrazolium agar (53) for E. coli (25) and L agar (36) for Listeria monocytogenes.
Isolation and cultivation of peritoneal macrophages. Peritoneal cells were isolated by intraperitoneal (i.p.) injection of 7 to 8 ml of RPMI 1640 medium (Gibco BRL, Grand Island, N.Y.) containing 5% fetal bovine serum (FBS), gentamicin (5 µg/ml), and heparin (5 U/ml) into mice that had been killed by cervical dislocation. Following i.p. injection, the mice were shaken to dislodge peritoneal cells and the lavage fluids were removed by syringe. The peritoneal cells were centrifuged (430 × g for 5 min), the resulting cell pellet was suspended in the aforementioned medium lacking heparin at a concentration of 5 × 105 cells/ml, and 0.5 ml of the cell suspension was placed into each well of a 48-well cell culture cluster plate (Costar, Cambridge, Mass.). Two hours later, the medium was removed and the plastic adherent cells were washed three times with 0.5 ml of Hanks balanced salt solution (HBSS) and then incubated in 0.5 ml of RPMI 1640 medium containing 5% FBS without antibiotics at 37°C in a humidified 5% CO2 incubator. Eighteen to twenty-four hours later, the culture medium was aspirated and the cells were washed once with HBSS and then incubated with 0.25 ml of the above culture medium lacking antibiotics. Elicitation of proteose peptone- or thioglycolate-elicited inflammatory macrophages was done by injecting mice i.p. with 2 ml of either sterile 10% proteose peptone (Difco, Detroit, Mich.) or thioglycolate broth (Remel, Kansas City, Mo.). Three days later, the peritoneal cells were harvested as described above.
In some experiments, macrophages were treated with gamma interferon (IFN-
) prior to use in the bacteriocidal assays. Immediately following the 2-h plastic adherence procedure, macrophages were incubated in medium containing 10 antiviral units of homogeneously pure
recombinant mouse IFN-
/ml (8.0 × 106 U/mg of
protein) for 18 to 24 h as previously reported (26, 47)
and then used in the bacteriocidal assays. The recombinant mouse
IFN-
(lot 2271-54-F2) was the kind gift of Genentech, Inc. (South
San Francisco, Calif.).
Cultivation of bone marrow-derived macrophages and macrophage cell lines. Bone marrow-derived macrophages were cultured as previously reported (20). IC-21 cells were grown in RPMI 1640-10% FBS. J774 cells were grown in Dulbecco minimal essential medium-Ham's F-12 mixture (1:1) with 10% FBS.
Macrophage bacteriocidal assay.
Macrophages in 48-well
tissue culture plates (~105 to 2 × 105
cells/well) containing 0.25 ml of RPMI 1640 medium were exposed to
approximately 106 bacteria added in 50 µl of PBS for 10 min at 37°C. After incubation, wells were washed four times (each
wash was with 1 ml of PBS). After the final wash, 0.5 ml of prewarmed
RPMI 1640 was added to each well. Gentamicin (2.5 µl of a 1-mg/ml
stock) was added to selected wells to produce a final concentration of
5 µg of gentamicin/ml. The addition of 0.1 ml of 1.0% Triton X-100
lysed the macrophages and defined the end of the incubation. One to two
minutes after the Triton X-100 additions, the contents of the wells
were diluted and plated. The brief exposure of bacteria to gentamicin
and Triton X-100 had no effect on bacterial viability. At each time
point, the contents of (typically) four wells were plated: two wells
contained macrophages, with each well having a mixture of
FimH+ and FimH
E. coli cells added
at approximately a 1:1 ratio. (Sometimes the two wells were duplicates;
occasionally one well had some other treatment.) The two remaining
wells did not have macrophages but were treated as if they did, both
before and after the addition of bacteria. In one of the wells,
gentamicin was added. In the last well gentamicin was omitted. In pilot
experiments, we found that a small number of bacteria remained bound to
the plastic of the wells without macrophages (1 to 10% of the
macrophage-bound bacteria). The bacteria in each of these wells were
used to assess the bacteriocidal kinetics of gentamicin when bacteria
were "unprotected" and bacterial growth in the absence of
gentamicin. Time points were spaced according to data from pilot
experiments, which indicated that >90% of unprotected bacteria were
eliminated after 20 to 25 min of exposure to gentamicin (establishing
the basis for the first time point) and that the numbers of
internalized bacteria were constant or tending upward after 4 h
(establishing the basis for the end of the assay). The number of
bacteria initially bound to macrophages was determined as described
above but just prior to the addition of gentamicin.
strains, which were
genetically marked by their abilities to utilize maltose
(25) (Table 1). The ratio of FimH+ to
FimH
E. coli cells obtained after macrophage
exposure was normalized to the starting
FimH+/FimH
ratio to determine if there was
any difference in the rate of macrophage killing based upon the FimH
phenotype. FimH+ and FimH
cells did not
differ in their gentamicin sensitivities (tested in the control well
lacking macrophages but with gentamicin) and did not differ noticeably
in their growth rates (determined in wells lacking macrophages and
gentamicin). Plating efficiencies on maltose tetrazolium agar,
previously noted as slightly different depending upon the Mal phenotype
(25), were not appreciably different under the present conditions.
Statistical analysis. Each experiment was typically performed with at least duplicate sets of wells. Standard deviations of the means of at least two separate experiments were calculated with the aid of the Microsoft Excel STDEV function. Standard error was calculated as the standard deviation divided by the square root of the number of experiments. All tabulated or illustrated values are the averages of at least two independent experiments. Regression analysis of the bacteriocidal curves was performed with the aid of the Microsoft Excel, version 5, trend line generator feature. Significant differences between means were determined by either Student's t test or analysis of variance. Both tests were provided by the Microsoft Excel, version 4, statistics package. The F statistic was also used to determine the probability of an accidental association of two variables in generating a trend line (Microsoft Excel, version 4). Statistically significant differences were defined as P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Analysis of macrophage killing curves.
In order to compare the
bacteriocidal activities of distinct macrophage populations from
different anatomical sites of different mouse strains, a standard was
needed. Pilot experiments revealed that the most consistent results
came from conditions that produced a final ratio (after washing off
unbound bacteria) of approximately 1 bound bacterium per 10 macrophages. This low multiplicity allowed direct comparisons between
FimH+ and FimH
bacteria in a single well
under noncompetitive binding conditions and reduced potentially
confounding effects associated with high multiplicities of infection
(e.g., endotoxin effects). At 20 to 25 min after gentamicin addition,
we began measuring the rate of killing. At least 90% of the bacteria
still viable at this time had been internalized by macrophages (and
were thus protected from gentamicin), but had not yet been killed. The
remaining ca. 10% were external bacteria that had not been killed by
gentamicin in the 25-min period. A considerable fraction (84 ± 41% of the total originally bound; 10 experiments averaged) of the
FimH+ and FimH
E. coli cells
initially bound (i.e., present immediately after washing) were still
viable after 20 to 25 min of gentamicin exposure, even in the most
bacteriocidal macrophage populations (unelicited peritoneal macrophages
from BALB/c mice; see below). The fate of this
"gentamicin-protected" population (set as 100%) over the next
4 h constituted our bacteriocidal curves. An example of one such
curve, along with two parameters associated with the trend line through
the points, is shown in Fig. 1. In this
example, the points on killing curves represent values averaged from
both FimH+ and FimH
E. coli.
|
Parameters employed to assess differences in bacteriocidal activity
between macrophage populations.
Regression analysis of linear,
exponential, and parabolic trend lines showed that the shape of most
bacteriocidal curves most closely matched that of a parabola. This is
reflected in the R2 statistic (coefficient of
determination), which gave the highest average value (a perfect
correlation produces an R2 value of 1.0) when 18 killing curves (employing unelicited peritoneal macrophages from
different mouse strains and with values for FimH+ and
FimH
E. coli averaged) were compared
(parabolic, R2 = 0.80 ± 0.17; linear
(first three points), R2 = 0.78 ± 0.24; exponential, R2 = 0.74 ± 0.16).
For the linear curve, only the first three time points were considered
because the killing curves departed from linearity relatively rapidly.
Data compiled from 15 different macrophage populations and 33 individual experiments revealed that the ordinate value of the vertex
of the parabolic trend line accurately and precisely predicted the
actual recorded minimum percentage of surviving E. coli
cells (FimH+ and FimH
cells averaged),
further indicating the natural parabolic shape of the killing curves
(Fig. 2A). Initial rate measurements (of both linear and parabolic curves) were less predictive of the ability
of a macrophage population to eliminate internalized E. coli
(reflected in the lower R2 statistic; Fig. 2B
and C). Nevertheless, rate measurements were linearly related to the
minimal percent surviving. This linear relationship was confirmed by
calculating the significance of the F statistic, which
indicates the probability of erroneously concluding that a linear
relationship exists (in all cases P < 0.05).
|
Comparison of the relative abilities of distinct macrophage
populations from different mouse strains to eliminate internalized
FimH+ and FimH
E. coli.
Peritoneal, bone marrow, and cell line macrophages derived from BALB/c
and C57BL/6 mice were initially compared for their abilities to
eliminate internalized FimH+ and FimH
E. coli. When results indicated that elicitation did not
enhance the rate or degree of killing of either FimH type of E. coli, elicitation methods were not employed for subsequent mouse
strains examined (CD-1, C3H/HeJ, and C3H/HeN). For C3H/He strains, only resident peritoneal macrophages were tested. In all macrophage populations tested, there was no statistically significant difference in the degree or rate at which FimH+ and FimH
E. coli cells were eliminated. Consequently, average
measurements of killing effectiveness include both FimH+
and FimH
E. coli.
|
E. coli binding characteristics of macrophage
populations in comparison to their bacteriocidal abilities.
Whereas we could find no difference in the abilities of macrophage
populations to eliminate FimH+ E. coli relative
to FimH
E. coli, they did differ in the
binding of FimH+ and FimH
cells (Fig.
4). The macrophage populations that bound
the highest ratios of FimH+ to FimH
bacteria
(bone marrow and cell line macrophages) were the populations least able
to kill E. coli once ingested. For BALB/c and C57BL/6 mice,
this trend was statistically significant only in distinguishing the
cell lines from the peritoneal and bone marrow-derived macrophages. For
the outbred CD-1 mice, where just bone marrow and unelicited peritoneal
macrophages were examined, there was a statistically significant
difference between these two macrophage populations with respect to
binding. There was no correlation between the absolute numbers of
E. coli cells bound per macrophage and the bacteriocidal
effectiveness. That is, the macrophage populations most effective at
killing internalized E. coli did not bind significantly more
of them. This was established in tests comparing unelicited macrophages
(used as one statistical grouping) and the other macrophage populations
(data not shown).
|
Examination of additional variables for macrophage bacteriocidal
ability.
The effect of serum in the assay, the recombination
proficiency of the ingested bacteria (their ability to repair DNA), and the effect of IFN-
treatment on macrophage bacteriocidal activity were examined. We tested the effect of FBS on macrophage bacteriocidal activity because E. coli antibodies, if elicited in utero,
had the potential to serve as opsonizing antibodies. However,
experiments done in the absence of serum had no significant effect upon
the binding or the subsequent rate or degree of killing of
FimH+ or FimH
E. coli. This was
true whether the serum was left out during the absorption period only
or left out of the macrophage preparation protocol and killing assay
entirely (data not shown).
had no effect upon the rate or degree to which FimH+ and FimH
E. coli cells were killed by unelicited macrophages from the BALB/c
and C57BL/6 strains (Fig. 5). IFN-
did
have a significant effect upon the degree to which L. monocytogenes was killed by unelicited peritoneal macrophages (the
lowest point in the killing curve); consequently the IFN-
did appear
to be having an effect on the macrophages. This effect of IFN-
on
macrophage killing of L. monocytogenes did not produce a
difference in the initial elimination rate of these microorganisms.
|
| |
DISCUSSION |
|---|
|
|
|---|
In the experiments described herein, we compared the innate
abilities of different macrophage populations from mice of different genetic backgrounds to kill internalized E. coli.
Bacteriocidal activity was measured by two parameters (i) the initial
elimination rate and (ii) the maximal percentage of internalized
E. coli eliminated. FimH+ and FimH
E. coli cells were used to assess the effects of different
bacterial cell surface interactions upon the binding and elimination of the bacteria once internalized. Additional assays that examined physiological and genetic factors that might influence the process were employed.
Quantitative bacteriocidal measurements which involved measuring the percentage of internalized bacteria eliminated were developed. Employing this measurement effectively normalized the results so that data from macrophages with different binding and uptake kinetics could be compared. We chose to present two measurements, (i) the initial rate and (ii) the degree to which an internalized population was eliminated. Of these two, the measurement of maximal percentage eliminated was found to be the more reproducible. In particular, we often found that high initial elimination rates often did not result in a high percentage of internalized bacteria eliminated. A similar observation was made by van Dissel et al. (60) with opsonized Salmonella enterica serovar Typhimurium.
Using regression analysis, we found that the ordinate value of the vertex of a parabola describing the killing curves predicted the maximal percentage of internalized bacteria eliminated quite well. In contrast, van Dissel et al. (60) found that opsonized S. enterica serovar Typhimurium underwent an exponential decrease after being taken up by macrophages over the 90-min period of their assays. An exponential decrease would be expected if pure probability determined elimination rate (i.e., the macrophages acting as a simple bacteriocidal agent). We expect that the parabolic shape coincidentally best described a dynamic state in which most ingested bacteria were being killed by macrophages in an exponential fashion but in which other ingested bacteria were growing, protected from the gentamicin by macrophages incapable of killing them (or not killing all of them). As time progressed, the replicative power of the protected E. coli began to be witnessed as the upward slope of the parabola. Consequently, the parabolic shape may be simply indicative of a generally inefficient process. However, the killing curve shape is not a widely analyzed feature of bacteriocidal assays. Future and retrospective attention to the shapes of killing curves may reveal unappreciated mechanistic relationships.
Both the initial linear elimination rate and the degree to which
internalized E. coli cells were eliminated supported the same order of macrophage bacteriocidal effectiveness, with resident and
proteose peptone-elicited peritoneal macrophages being consistently the
best, followed by, in declining order of effectiveness,
thioglycolate-elicited peritoneal macrophages, bone marrow-derived
macrophages, and macrophage-like cell lines. The killing curves of
macrophage populations that eliminated approximately 60% (or less) of
the ingested bacteria had significantly lower R2
values (for linear or parabolic curves), and the curve parameters had
higher standard deviations, than those of macrophage populations killing greater than 90% of the ingested bacteria. We found it difficult to draw any conclusions about the killing capacities of
macrophage populations in this low-level killing category. The
inability of thioglycolate-elicited macrophages to efficiently kill
bacteria has been often reported (7, 18, 27, 57). Likewise,
our observation that macrophage cell lines and bone marrow-derived
macrophages were inefficient at killing internalized bacteria, compared
to unelicited peritoneal macrophages, was consistent with those of
others (9, 46-48). However, bone marrow-derived macrophages
have been frequently used in bacterial phagocytosis assays (3,
46). When bone marrow-derived macrophages were examined with
FimH+ E. coli (3), the degree to
which FimH+ E. coli cells were eliminated was
found to be similar to that reported here (FimH
E. coli cells were not tested previously [3]).
Mouse genetic background had no effect on the in vitro bacteriocidal capacity of macrophages even though the strains of mice differ rather dramatically in their susceptibilities to gram-negative and gram-positive bacterial pathogens (33) (Table 1). We were somewhat surprised that there was no effect. However, susceptibility to bacterial infection, as it relates to macrophage bacteriocidal effectiveness, depends upon a number of factors, among them the type of bacteria under investigation (17, 51) and whether the bacteria are opsonized or not (1, 28, 60). Our results indicate that the innate susceptibility of mice to a variety of bacterial infections does not correlate with the ability of host macrophages to take up or kill unopsonized E. coli.
Whereas previous experiments have shown statistically significant
differences between the survival of FimH+ E. coli and that of FimH
E. coli in resident
peritoneal macrophages (25), we witnessed no such
differences here. The assay conditions, the criteria used to assess
killing, and the magnitude of the differences shown in this earlier
report leave open the possibility that there may be little difference
between the killing of FimH+ and FimH
E. coli once internalization has occurred. Consequently, our results support observations that piliation has little effect on the
outcome of nonopsonic phagocytosis as far as killing of ingested
bacteria is concerned (5, 6, 16, 22). Our results leave open
the possibility that FimH+ and FimH
E. coli cells are directed to different vacuolar compartments once
internalized (analogous to FimH+ and opsonized E. coli) (3) but indicate that this hypothetical difference in trafficking makes no effective difference in terms of
killing, at least as measured by the methods we employed.
Whereas the killing of ingested bacteria was not influenced by the
FimH+ or the FimH
phenotype, macrophage
populations were found to have distinctly different binding properties
when the ratios of FimH+ to FimH
E. coli bound were compared. We attribute these binding differences to different FimH receptor densities (3, 13) on the various macrophage populations relative to the densities of receptors that
simply bind FimH
E. coli via another mechanism
or mechanisms (e.g., via lipopolysaccharide [64]).
Interestingly, the macrophage populations least effective in killing
ingested E. coli exhibited the highest relative binding of
FimH+ E. coli. The biological significance of
this is unknown. Since a number of different receptors have been
proposed to have a role in binding FimH on phagocytic cells (3,
14, 24, 52), it may be that certain macrophage populations vary
in the expression of receptor type as well as density.
Two factors that have been shown to affect the fate of bacteria
internalized by macrophages are (i) recombination proficiency, shown to
be a factor in the survival of (opsonized) S. enterica serovar Typhimurium (10) and (ii) the exogenous addition of IFN-
, shown to affect the fate of unopsonized L. monocytogenes (47) and opsonized S. enterica
serovar Typhimurium (23, 48), as well as the phagocytosis of
unopsonized E. coli (49, 50; killing was
not measured in these reports). Neither of these factors appears to
affect the rate or degree to which unopsonized E. coli cells
(FimH+ or FimH
) were killed as measured by
our methods, although control experiments showed that IFN-
did
significantly improve the degree to which unopsonized L. monocytogenes was eliminated, as has been previously reported
(47). Understanding the reason for the differential effect
of IFN-
may aid in understanding the molecular mechanisms by which
certain bacteria are able to thwart macrophage killing. Under our assay
conditions, the addition of heat-inactivated 5% FBS to unelicited
peritoneal macrophages had no significant effect upon the binding or
subsequent killing of FimH+ E. coli as has been
previously reported (3). It may be that FBS effects are
manifested only under certain conditions or with certain macrophage populations.
There are many complex biochemical events involved in the
internalization and killing of bacteria by phagocytes. In vitro assays
to quantify bacterial killing by macrophages can provide useful
insights into host-pathogen interactions. However, there are numerous
variables in such assays that make comparisons from different
laboratories difficult. In the present study, we systematically examined several of the principal assay variables for their effects on
the fate of phagocytized, unopsonized E. coli. We found that several factors previously reported to influence the microbicidal activity of macrophages, such as the presence or absence of serum, activation of the macrophage by IFN-
, recombination proficiency of
the bacteria, FimH phenotype, and the mouse strain background of the
macrophage population had no effect. Of relevance for future studies
was our finding that the anatomical source of macrophages and their
derivation significantly influenced bacteriocidal activity.
| |
ACKNOWLEDGMENTS |
|---|
We thank Craig Altier for a critical reading of the manuscript and helpful suggestions.
This work was supported by grant AI 222223 from the Public Health Service and the State of North Carolina.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, Pathology, and Parasitology, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough St., Raleigh, NC 27606. Phone: (919) 513-6207. Fax: (919) 513-6455. E-mail: Paul_Orndorff{at}ncsu.edu.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alpuche-Aranda, C. M., E. P. Berthiaume, B. Mock, J. A. Swanson, and S. I. Miller. 1995. Spacious phagosome formation within mouse macrophages correlates with Salmonella serotype pathogenicity and host susceptibility. Infect. Immun. 63:4456-4462[Abstract]. |
| 2. |
Archinal, W. A., and M. S. Wilder.
1988.
Susceptibility of HRS/J mice to listeriosis: macrophage activity.
Infect. Immun.
56:613-618 |
| 3. | Baorto, D. M., Z. Gao, R. Malaviya, M. L. Dustin, A. van der Merwe, D. M. Lublin, and S. N. Abraham. 1997. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature 389:636-639[CrossRef][Medline]. |
| 4. | Bloch, C. A., B. A. D. Stocker, and P. E. Orndorff. 1992. A key role for type 1 pili in enterobacterial communicability. Mol. Microbiol. 6:697-701[CrossRef][Medline]. |
| 5. |
Blumenstock, F., and K. Jann.
1982.
Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and mannose-resistant pili.
Infect. Immun.
35:264-269 |
| 6. | Boner, G., A. M. Mhashilkar, M. Rodriguez-Ortega, and N. Sharon. 1989. Lectin-mediated, nonopsonic phagocytosis of type 1 Escherichia coli by human peritoneal macrophages of uremic patients treated by peritoneal dialysis. J. Leukoc. Biol. 46:239-245[Abstract]. |
| 7. |
Briles, D. E.,
J. Lehmeyer, and C. Forman.
1981.
Phagocytosis and killing of Salmonella typhimurium by peritoneal exudate cells. 1981.
Infect. Immun.
33:380-388 |
| 8. | Brinton, C. C., Jr. 1965. The structure, function, synthesis and genetic control of bacterial pili and a molecular model of DNA and RNA transport in gram negative bacteria. Trans. N.Y. Acad. Sci. 27:1003-1054[Medline]. |
| 9. |
Buchmeier, N. A., and F. Heffron.
1989.
Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages.
Infect. Immun.
57:1-7 |
| 10. | Buchmeier, N. A., C. J. Lipps, M. Y. So, and F. Heffron. 1993. Recombination-deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages. Mol. Microbiol. 7:933-936[Medline]. |
| 11. |
Cheers, C., and I. C. McKenzie.
1978.
Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis.
Infect. Immun.
19:755-762 |
| 12. | Duguid, J. P., and D. C. Old. 1980. Adhesive properties of Enterobacteriaceae, p. 187-217. In E. H. Beachey (ed.), Bacterial adherence: receptors and recognition, vol. 6. Chapman and Hall, London, United Kingdom. |
| 13. | Gbarah, A., C. G. Gahmberg, G. Boner, and N. Sharon. 1993. The leukocyte surface antigens CD11b and CD18 mediate the oxidative burst activation of human peritoneal macrophages induced by type 1 fimbriated Escherichia coli. J. Leukoc. Biol. 54:111-113[Abstract]. |
| 14. |
Gbarah, A.,
C. G. Gahmberg,
I. Ofek,
U. Jacobi, and N. Sharon.
1991.
Identification of the leukocyte adhesion molecules CD11 and CD18 as receptors for type 1-fimbriated (mannose-specific) Escherichia coli.
Infect. Immun.
59:4524-4530 |
| 15. |
Gbarah, A.,
D. Mirelman,
P. J. Sansonetti,
R. Verdon,
W. Bernhard, and N. Sharon.
1993.
Shigella flexneri transformants expressing type 1 (mannose-specific) fimbriae bind to, activate, and are killed by phagocytic cells.
Infect. Immun.
61:1687-1693 |
| 16. | Goetz, M. B., S. M. Kuriyama, and F. J. Silverblatt. 1987. Phagolysosome formation by polymorphonuclear neutrophilic leukocytes after ingestion of Escherichia coli that express type 1 pili. J. Infect. Dis. 156:229-233[Medline]. |
| 17. |
Hancock, G. E.,
R. W. Schaedler, and T. T. MacDonald.
1986.
Yersinia enterocolitica infection in resistant and susceptible strains of mice.
Infect. Immun.
53:26-31 |
| 18. |
Harrington-Fowler, L.,
P. M. Henson, and M. S. Wilder.
1981.
Fate of Listeria monocytogenes in resident and activated macrophages.
Infect. Immun.
33:11-16 |
| 19. |
Harris, S. L.,
D. A. Elliott,
M. C. Blake,
L. M. Must,
M. Messenger, and P. E. Orndorff.
1990.
Isolation and characterization of mutants that have lesions affecting receptor-binding of type 1 pili in Escherichia coli.
J. Bacteriol
172:6411-6418 |
| 20. | Havell, E. A., and G. L. Spitalny. 1980. The induction and characterization of interferon from pure cultures of murine macrophages. Ann. N.Y. Acad. Sci. 350:413-421[CrossRef][Medline]. |
| 21. | Hernychova, L., H. Kovarova, A. Macela, M. Kroca, Z. Krocova, and J. Stulik. 1997. Early consequences of macrophage-Francisella tularensis interaction under the influence of different genetic background in mice. Immunol. Lett. 57:75-81[CrossRef][Medline]. |
| 22. |
Iwahi, T., and A. Imada.
1988.
Interaction of Escherichia coli with polymorphonuclear leukocytes in pathogenesis of urinary tract infection in mice.
Infect. Immun.
56:947-953 |
| 23. |
Kagaya, K.,
K. Watanabe, and Y. Fukazawa.
1989.
Capacity of recombinant gamma interferon to activate macrophages for Salmonella killing activity.
Infect. Immun.
57:609-615 |
| 24. | Karlsson, A., S. R. Carlsson, and C. Dahlgren. 1996. Identification of the lysosomal membrane glycoprotein Lamp-1 as a receptor for type-1-fimbriated (mannose-specific) Escherichia coli. Biochem. Biophys. Res. Commun. 219:168-172[CrossRef][Medline]. |
| 25. |
Keith, B. R.,
S. L. Harris,
P. W. Russell, and P. E. Orndorff.
1990.
Effect of type 1 piliation on in vitro killing of Escherichia coli by mouse peritoneal macrophages.
Infect. Immun.
58:3448-3454 |
| 26. | Koestler, T. P., A. M. Badger, D. J. Rieman, R. Greig, and G. Poste. 1985. Induction by immunomodulatory agents of a macrophage antigen recognized by monoclonal antibody 158.2 and correlation with macrophage function. Cell. Immunol. 96:113-125[CrossRef][Medline]. |
| 27. |
Leijh, P. C.,
T. L. van Zwet,
M. N. ter Kuile, and R. van Furth.
1984.
Effect of thioglycolate on phagocytic and microbicidal activities of peritoneal macrophages.
Infect. Immun.
46:448-452 |
| 28. | Lissner, C. R., D. L. Weinstein, and A. D. O'Brien. 1985. Mouse chromosome I Ity locus regulates microbicidal activity of isolated peritoneal macrophages against a diverse group of intracellular and extracellular bacteria. J. Immunol. 135:544-547[Abstract]. |
| 29. |
Lock, R.,
C. Dahlgren,
M. Linden,
O. Stendahl,
A. Svensbergh, and L. Ohman.
1990.
Neutrophil killing of two type 1 fimbria-bearing Escherichia coli strains: dependence on respiratory burst activation.
Infect. Immun.
58:37-42 |
| 30. | Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381:77-80[CrossRef][Medline]. |
| 31. | Malaviya, R., E. Ross, B. A. Jakschik, and S. N. Abraham. 1994. Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice. J. Clin. Investig. 93:1645-1653. |
| 32. | Malaviya, R., E. A. Ross, J. I. MacGregor, T. Ikeda, J. R. Little, B. A. Jakschik, and S. N. Abraham. 1994. Mast cell phagocytosis of FimH-expression enterobacteria. J. Immunol. 152:1907-1914[Abstract]. |
| 33. | Malo, D., and E. Skamene. 1994. Genetic control of host resistance to infection. Trends Genet. 10:365-371[CrossRef][Medline]. |
| 34. | Mauel, J., and V. DeFendi. 1971. Infection and transformation of mouse peritoneal macrophages by simian virus 40. J. Exp. Med. 134:335-350[Abstract]. |
| 35. |
Maurer, L. M., and P. E. Orndorff.
1987.
Identification and characterization of genes determining receptor binding and pilus length of Escherichia coli type 1 pili.
J. Bacteriol.
169:640-645 |
| 36. | Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 37. | Murray, E. G. D., R. A. Webb, and M. B. R. Swann. 1926. A disease of rabbits characterized by large mono-nuclear leukocytosis caused by a heretofore undescribed bacillus Bacterium monocytogenes. J. Pathol. Bacteriol. 29:407-412[CrossRef]. |
| 38. |
O'Brien, A. D.
1982.
Innate resistance of mice to Salmonella typhi infection.
Infect. Immun.
38:948-952 |
| 39. | Ofek, I., J. Goldhar, Y. Keisari, and N. Sharon. 1995. Nonopsonic phagocytosis of microorganisms. Annu. Rev. Microbiol. 49:239-276[CrossRef][Medline]. |
| 40. |
Ofek, I., and N. Sharon.
1988.
Lectinophagocytosis: a molecular mechanism of recognition between cell surface sugars and lectins in the phagocytosis of bacteria.
Infect. Immun.
56:539-547 |
| 41. | Ohman, L., J. Hed, and O. Stendahl. 1982. Interaction between human polymorphonuclear leukocytes and two different strains of type-1 fimbriae-bearing Escherichia coli. J. Infect. Dis. 146:751-757[Medline]. |
| 42. | Orndorff, P. E., and C. A. Bloch. 1990. The role of type 1 pili in the pathogenesis of Escherichia coli infections: a short review and some new ideas. Microb. Pathog. 9:75-79[CrossRef][Medline]. |
| 43. |
Orndorff, P. E.,
P. A. Spears,
D. Schauer, and S. Falkow.
1985.
Two modes of control of pilA, the gene encoding type 1 pilin in Escherichia coli.
J. Bacteriol.
164:321-330 |
| 44. |
Poltorak, A.,
X. He,
I. Smirnova,
M. Y. Liu,
C. V. Huffel,
X. Du,
D. Birdwell,
E. Alejos,
M. Silva,
C. Galanos,
M. Freudenberg,
P. Ricciardi-Castagnoli,
B. Layton, and B. Beutler.
1998.
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
Science
282:2085-2088 |
| 45. |
Ponniah, S.,
S. N. Abraham, and R. O. Endres.
1992.
T-cell-independent stimulation of immunoglobulin secretion in resting human B lymphocytes by the mannose-specific adhesin of Escherichia coli type 1 fimbriae.
Infect. Immun.
60:5197-5203 |
| 46. |
Portnoy, D. A.,
P. S. Jacks, and D. J. Hinrichs.
1988.
Role of hemolysin for the intracellular growth of Listeria monocytogenes.
J. Exp. Med.
167:1459-1471 |
| 47. |
Portnoy, D. A.,
R. D. Schreiber,
P. Connelly, and L. G. Tilney.
1989.
Gamma interferon limits access of Listeria monocytogenes to the macrophage cytoplasm.
J. Exp. Med.
170:2141-2146 |
| 47a. | Ralph, P., and I. Nakoinz. 1975. Phagocytosis by a macrophage tumor and its clonal cell line. Nature 257:393-394[CrossRef][Medline]. |
| 48. | Riikonen, P., P. H. Makela, H. Saarilahti, S. Sukupolvi, S. Taira, and M. Rhen. 1992. The virulence plasmid does not contribute to growth of Salmonella in cultured murine macrophages. Microb. Pathog. 13:281-291[CrossRef][Medline]. |
| 49. | Rollag, H., and M. Degre. 1981. Effect of interferon preparations on the uptake of non-opsonized Escherichia coli by mouse peritoneal macrophages. Acta Pathol. Microbiol. Scand. Sect. B. 89:153-159[Medline]. |
| 50. | Rollag, H., M. Degre, and G. Sonnenfeld. 1984. Effects of interferon-alpha/beta and interferon-gamma preparation on phagocytosis by mouse peritoneal macrophages. Scand. J. Immunol. 20:149-155[CrossRef][Medline]. |
| 51. | Sapru, K., P. K. Stotland, and M. M. Stevenson. 1999. Quantitative and qualitative differences in bronchoalveolar inflammatory cells in Pseudomonas aeruginosa-resistant and -susceptible mice. Clin. Exp. Immunol. 115:103-109[CrossRef][Medline]. |
| 52. |
Sauter, S. L.,
S. M. Rutherfurd,
C. Wagener,
J. E. Shively, and S. A. Hefta.
1993.
Identification of the specific oligosaccharide sites recognized by type 1 fimbriae from Escherichia coli on nonspecific cross-reacting antigen, a CD66 cluster granulocyte glycoprotein.
J. Biol. Chem.
268:15510-15516 |
| 53. | Silhavy, T. J., M. L. Berman, and L. W. Enquist. 1984. Experiments with gene fusions, p. 102. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 54. |
Silverblatt, F. J.,
J. S. Dreyer, and S. Schauer.
1979.
Effect of pili on susceptibility of Escherichia coli to phagocytosis.
Infect. Immun.
24:218-223 |
| 55. | Silverblatt, F. J., and I. Ofek. 1983. Interaction of bacterial pili and leukocytes. Infection 11:235-238[CrossRef][Medline]. |
| 56. |
Spears, P. A.,
D. Schauer, and P. E. Orndorff.
1986.
Metastable regulation of type 1 piliation in Escherichia coli and isolation and characterization of a phenotypically stable mutant.
J. Bacteriol.
168:179-185 |
| 57. |
Spitalny, G. L.
1981.
Dissociation of bactericidal activity from other functions of activated macrophages in exudates induced by thioglycolate medium.
Infect. Immun.
34:274-284 |
| 58. |
Tewari, R.,
J. I. MacGregor,
T. Ikeda,
J. R. Little,
S. J. Hultgren, and S. N. Abraham.
1993.
Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli.
J. Biol. Chem.
268:3009-3015 |
| 59. | Valenti-Weigand, P., P. Benkel, M. Rohde, and G. S. Chhatwal. 1996. Entry and intracellular survival of group B streptococci in J774 macrophages. Infect. Immun. 64:2467-2473[Abstract]. |
| 60. | van Dissel, J. T., P. C. J. Leijh, and R. van Furth. 1985. Differences in initial rate of intracellular killing of Salmonella typhimurium by resident peritoneal macrophages from various mouse strains. J. Immunol. 134:3404-3410[Abstract]. |
| 61. | Weinstein, D. L., C. R. Lissner, R. N. Swanson, and A. D. O'Brien. 1986. Macrophage defect and inflammatory cell recruitment dysfunction in Salmonella susceptible C3H/HeJ mice. Cell. Immunol. 102:68-77[CrossRef][Medline]. |
| 62. | Weinstein, R., and F. J. Silverblatt. 1983. Antibacterial mechanisms of antibody to mannose-sensitive pili of Escherichia coli. J. Infect. Dis. 147:882-889[Medline]. |
| 63. |
Woodall, L. D.,
P. W. Russell,
S. L. Harris, and P. E. Orndorff.
1993.
Rapid, synchronous, and stable induction of type 1 piliation in Escherichia coli using a chromosomal lacUV5 promoter.
J. Bacteriol.
175:2770-2778 |
| 64. |
Wright, S. D., and M. T. C. Jong.
1986.
Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide.
J. Exp. Med.
164:1876-1888 |
| 65. |
Yoshida, S.,
Y. Goto,
Y. Mizuguchi,
K. Nomoto, and E. Skamene.
1991.
Genetic control of natural resistance in mouse macrophages regulating intracellular Legionella pneumophila multiplication in vitro.
Infect. Immun.
59:428-432 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»